Confocal Scanning Infrared Laser Ophthalmoscopy for Indocyanine Green Angiography - 26/08/14
Résumé |
Purpose |
We used indocyanine green to study wavelength-optimized confocal scanning infrared laser angiography in patients with retinal and choroidal disease.
Methods |
A confocal scanning laser ophthalmoscope with an excitation wavelength of 795 nm was operated both in tight and wide confocal imaging modes. We examined 77 subjects with and without retinal and choroidal disease (including diabetic retinopathy, age-related macular degeneration, and subretinal neovascularization).
Results |
The scanning laser ophthalmoscope allowed acquisition of images, in the wide confocal imaging mode, of the retinal circulation and late leakage sites without late injections of dye to outline the retinal vasculature. In the tight confocal imaging mode, optical subtraction of the light contribution of the retinal circulation allowed examination of the choroidal circulation, and vice versa. The wide confocal mode appears equivalent to other scanning laser ophthalmoscopes in recording images from retinal and choroidal layers.
Conclusions |
There are three differences between the confocal scanning laser ophthalmoscope and conventional instruments. First, the late images allow excellent visualization of the retinal circulation without a landmark injection. Second, confocal imaging allows optical subtraction of retinal circulation when focusing on the choroid and vice versa. Third, the instrument acquires and processes all data digitally, is personal computer-based, is compact, operates with a mouse-driven graphical user interface, and allows easy data exchange with conventional software. With further modifications in software and hardware, this device offers the possibility of producing a three-dimensional map of the retinal and choroidal vasculature.
Le texte complet de cet article est disponible en PDF.| This study was supported in part by grants from the Charles H. and Anna S. Stern Foundation, La Jolla, California (Dr. Freeman); and from the San Diego Eye Bank, San Diego, California (Dr. Freeman); the 1992 Alcon Research Institute Prize, Fort Worth, Texas (Dr. Weinreb); and unrestricted grants from Research to Prevent Blindness, Inc., New York, New York (Department of Ophthalmology, University of California San Diego). Dr. Zinser is an officer of Heidelberg Engineering, the company that assembles the instrument described in this study. Dr. Bartsch is a consultant for Heidelberg Engineering. Reprint requests to Dirk-Uwe Bartsch, Ph.D., UCSD Shiley Eye Center, University of California San Diego, 9415 Campus Point Dr., 0946, La Jolla, CA 92093-0946; fax: (619) 534-7985; E-mail: dbartsch@ucsd.edu. |
Vol 120 - N° 5
P. 642-651 - novembre 1995 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
